● Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Condition: Gastroesophageal Adenocarcinoma · Sponsor: AstraZeneca

PhasePhase 2

Planned participants100

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as perioperative treatment in participants with locally advanced resectable gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma who have not received previous treatment for the disease.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (70)

Research Site	Newark, Delaware, United States	Recruiting
Research Site	Washington D.C., District of Columbia, United States	Recruiting
Research Site	Fairway, Kansas, United States	Recruiting
Research Site	North Shores, Michigan, United States	Recruiting
Research Site	New York, New York, United States	Not Yet Recruiting
Research Site	New York, New York, United States	Recruiting
Research Site	Pittsburgh, Pennsylvania, United States	Not Yet Recruiting
Research Site	Toronto, Ontario, Canada	Suspended
Research Site	Montreal, Quebec, Canada	Recruiting
Research Site	Montreal, Quebec, Canada	Recruiting
Research Site	Beijing, China	Recruiting
Research Site	Changchun, China	Recruiting

+ 58 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07069712